Wet AMD Treatments: Updates, Challenges, and Future Innovations

Charles C. Wykoff, MD, PhD is Director of Research at Retina Consultants of Texas; Chairman of Research, Retina Consultants of America; Deputy Chair of Ophthalmology for the Blanton Eye Institute, Houston Methodist Hospital; and Clinical Professor of Ophthalmology, Weill Cornell Medical College. He received his baccalaureate from MIT, PhD from Oxford University while on a Marshall Scholarship, MD from Harvard Medical School and completed retina fellowship at Bascom Palmer Eye Institute where he served as Chief Resident/Co-Director of Ocular Trauma and received a Heed Fellowship and the Ronald G. Michels Award.

He is passionate about translational research and accelerating drug and device development. He has published over 325 peer-reviewed manuscripts and serves on multiple scientific and medical advisory boards, safety monitoring committees, and global steering committees for endeavors spanning the innovative process from early to late-stage developments. He serves on the ASRS Executive Committee and Board of Directors, is a founding member of the Ophthalmology Retina Editorial Board, and a past President of the Vit-Buckle Society for which he is an Emeritus member of the Board of Trustees.  He is a member of the NEI Audacious Goals Steering Committee and has been awarded multiple Achievement, Honor and Senior Honor Awards including the ASRS Young Investigator and the AAO Secretariat Awards.  His guiding philosophy is to build and strengthen innovative, ethical teams focused on developing new approaches to improving outcomes for patients with blinding diseases.